The mouth carries a chronic‑cost warning light most health plans can't access.
Nesso Health turns a routine periodontal exam into an early risk signal across eight of the costliest chronic conditions — captured at a visit your population already attends.
Your highest-risk members are already sitting in a dental chair.
Health systems, ACOs, TPAs, and self-insured employers spend heavily on chronic disease management downstream — after the diagnosis, after the ER visit, after the cost has already landed. Periodontal disease is a validated leading indicator for the conditions driving that spend, and it's captured at a visit your population already attends. Today, that data stops at the dental chart. Oral care delivers outsized chronic disease impact. Coordination with medical is what unlocks it.
- 01 Dental and medical claims are adjudicated separately, so periodontal risk never reaches a care manager.
- 02 Chronic disease programs enroll members after a diagnosis, not before one.
- 03 Employers and TPAs pay for both dental benefits and chronic disease spend without connecting the two.
- 04 Dentists are trained to see the signal, but have no structured way to route it to the people who manage the risk.
- 05 Only a select group of dentists take vitals that provide critical information for chronic disease identification and management.
From chairside exam to a routed risk score.
The ClarioPath™ Assessment Report was built to fit inside a workflow that already exists, not replace it.
Capture at the chair
Periodontal disease scores combined with vitals and health history collected during a routine exam are submitted from the dental practice — no extra visit, no extra device.
Score across 8 conditions
The ClarioPath™ Assessment Report converts periodontal findings into management and risk scores for cardiovascular disease, diabetes, kidney disease, osteoporosis (OP), dementia, sleep apnea, pregnancy complications, and oral cancer.
Route to care management
Elevated-risk scores are routed to the health plan, ACO, or care management team already responsible for that member — early enough to act on it.
Not a referral. A clinical trigger.
Not a cleaning receipt. A scored, banded assessment written for the patient and the physician — with the chairside findings that produced it, an interpretation, and a recommendation the care team can act on.
Every element below comes from a single routine dental encounter. No new tests, no new site of care, no additional visit.
Intensive periodontal therapy with medical coordination. Report transmitted to the attributed primary care team as a documented clinical trigger — supporting HbA1c and blood pressure care gap closure, and available to the Annual Wellness Visit and Chronic Care Management workflow.
De-identified sample report. Not a patient record. ClarioPath™ scores are decision-support tools, not a diagnosis; all findings require physician confirmation.
Built on the conditions that drive your medical spend.
Each condition below has a documented periodontal-disease correlation. The ClarioPath™ assessment scores risk across all eight from a single exam.
Cardiovascular disease
Inflammatory pathway linked to atherosclerosis and cardiac events.
Diabetes
Bidirectional relationship with glycemic control and complication risk.
Kidney disease
Periodontal inflammation associated with declining renal function.
Osteoporosis (OP)
Periodontal bone loss tracks with systemic bone density decline.
Dementia
Chronic oral inflammation is associated with elevated cognitive decline risk.
Sleep apnea
Airway and oral structure findings surface undiagnosed cases.
Pregnancy complications
Associated with preterm birth and low birth weight risk.
Oral cancer
Direct screening opportunity at the source of the exam.
Grounded in a peer-reviewed foundation.
The ClarioPath™ Assessment Report builds on published, actuarial-grade research — not a theory of what dental data might predict.
“Oral diseases are interconnected with major noncommunicable diseases (NCDs), sharing common risk factors. Poor oral health is linked to cardiovascular diseases, diabetes, cancers, and chronic respiratory diseases.”World Health Organization, 2022
This is not a single study or an emerging hypothesis. More than 50 cohort studies covering over 4 million patients link periodontal disease to cardiovascular disease, stroke, and diabetes — and that count is conservative. At the umbrella level, 293 systematic reviews spanning 855 meta-analytic comparisons across 28 noncommunicable diseases have examined the oral–systemic relationship, with 41 systematic reviews and 839 primary studies on cardiovascular disease alone. The ClarioPath™ Assessment Report operationalizes that body of evidence into a routable risk signal.
Built for the organizations that own the cost of chronic disease.
Close the medical-dental gap in your risk models.
Health systems and ACOs carry downside risk on the same chronic conditions periodontal disease predicts. The ClarioPath™ Assessment Report gives your population health team a validated, early risk signal from a visit type your risk-adjustment models currently treat as invisible.
No new benefit. No new vendor. A cost lever you already fund.
You are already paying for dental. You are already paying for chronic disease claims. They are adjudicated as separate line items by different administrators, so the risk signal sitting in one never reaches the team managing the other. ClarioPath™ routes it — into the disease management and stop-loss strategy you already run, with nothing new for members to enroll in, learn, or be sold on. The spend is committed either way. The only question is whether you get the medical value out of it.
The physical touchpoint your model can't reach through a screen.
Virtual-first care has one structural limit: nobody takes a blood pressure over video. Your members sit in a dental chair on a recall schedule anyway — examined in person, vitals in hand, by a clinician they already trust. ClarioPath™ captures that encounter and routes it to you: real vitals, a periodontal risk score, and members surfaced before a diagnosis triggers enrollment. It is added exposure to the patient, on a cadence you don't have to create, with no new outreach competing for their attention.
Know which pregnancies to watch, earlier.
A single NICU admission averages $71,158 in employer-sponsored plans, and 18% of newborns need some level of NICU care. Your entire model depends on identifying the pregnancies headed there before they get there. Periodontal disease is a validated marker for exactly that population — associated with 2.2× the odds of preeclampsia and 1.6× the risk of preterm birth. ClarioPath™ turns a routine dental exam into an early stratification signal, so your care team knows where to concentrate before the second trimester.
Two patients. Same exam. Very different visit.
Every dentist is trained to recognize the signs. What separates a Nesso Health provider is what happens next.
The finding stops at the chart.
- —Periodontal probing performed and charted as a dental problem.
- —No vitals taken. No blood pressure, no current medication reconciliation.
- —Health history collected once at intake and rarely revisited.
- —Referrals go to other dentists. The patient's physician is never contacted.
- —The patient is told to floss more. The only paperwork received is the bill.
The finding becomes clinical intelligence.
- 01Periodontal scores captured alongside vitals and a current health history — the way a medical encounter is documented.
- 02Findings scored against eight chronic conditions, not filed as an isolated dental issue.
- 03Disease management and elevated risk scores are routed to the physician or care team responsible for that patient, in a form their system can use.
- 04Undiagnosed disease gets surfaced — 20–40% of periodontal patients screened have undiagnosed diabetes or prediabetes.
- 05Similar to a physician visit summary, the patient leaves with a report — understanding the impact their oral health has on the rest of their body.